drugset / Trial / NCT00392067

LEO19123 Cream in the Treatment of Atopic Dermatitis

NCT00392067

Phase 2 Completed 75 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and safety of two different dose combinations of LEO19123 (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with atopic dermatitis

Timeline

Start
2006-10
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule
Subject LEO80122 Unknown

Indications